MedPath
HSA Approval

METRONIDAZOLE FRESENIUS SOLUTION FOR INFUSION 500 mg/100 ml

SIN11737P

METRONIDAZOLE FRESENIUS SOLUTION FOR INFUSION 500 mg/100 ml

METRONIDAZOLE FRESENIUS SOLUTION FOR INFUSION 500 mg/100 ml

November 27, 2001

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

J01XD01

metronidazole

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI DEUTSCHLAND GMBH

Fresenius Kabi Polska Sp. z o.o.

Active Ingredients

METRONIDAZOLE

500 mg/100 ml

Metronidazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METRONIDAZOLE FRESENIUS SOLUTION FOR INFUSION 500 mg/100 ml - HSA Approval | MedPath